189 related articles for article (PubMed ID: 36579732)
1. Treatment and mortality of hemophagocytic lymphohistiocytosis in critically ill children: A systematic review and meta-analysis.
Tan CJ; Ng ZQ; Bhattacharyya R; Sultana R; Lee JH
Pediatr Blood Cancer; 2023 Mar; 70(3):e30122. PubMed ID: 36579732
[TBL] [Abstract][Full Text] [Related]
2. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
[TBL] [Abstract][Full Text] [Related]
4. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.
Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M
Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU.
Gregory J; Greenberg J; Basu S
Pediatr Crit Care Med; 2019 Apr; 20(4):e185-e190. PubMed ID: 30520798
[TBL] [Abstract][Full Text] [Related]
7. Critically Ill Children With Hemophagocytic Lymphohistiocytosis: A Case Series of 14 Patients.
Leow EH; Soh SY; Tan AM; Mok YH; Chan MY; Lee JH
J Pediatr Hematol Oncol; 2017 Aug; 39(6):e303-e306. PubMed ID: 28697170
[TBL] [Abstract][Full Text] [Related]
8. Severe Dengue and Associated Hemophagocytic Lymphohistiocytosis in PICU.
Bhattacharya D; Angurana SK; Nallasamy K; Iyer R; Jayashree M
Indian J Pediatr; 2019 Dec; 86(12):1094-1098. PubMed ID: 31353429
[TBL] [Abstract][Full Text] [Related]
9. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
10. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
[TBL] [Abstract][Full Text] [Related]
11. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
[TBL] [Abstract][Full Text] [Related]
12. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
[TBL] [Abstract][Full Text] [Related]
13. Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis.
Valade S; Azoulay E; Galicier L; Boutboul D; Zafrani L; Stepanian A; Canet E; Lemiale V; Venot M; Veyradier A; Mariotte E
Medicine (Baltimore); 2015 Oct; 94(40):e1692. PubMed ID: 26448017
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit].
Eichenauer DA; La Rosée P
Inn Med (Heidelb); 2023 Oct; 64(10):955-960. PubMed ID: 37702780
[TBL] [Abstract][Full Text] [Related]
16. Treatment and Mortality of Hemophagocytic Lymphohistiocytosis in Adult Critically Ill Patients: A Systematic Review With Pooled Analysis.
Knaak C; Schuster FS; Nyvlt P; Spies C; Feinkohl I; Beutel G; Schenk T; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Crit Care Med; 2020 Nov; 48(11):e1137-e1146. PubMed ID: 32947471
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis.
Aulagnon F; Lapidus N; Canet E; Galicier L; Boutboul D; Peraldi MN; Reuter D; Bernard R; Schlemmer B; Azoulay E; Zafrani L
Am J Kidney Dis; 2015 Jun; 65(6):851-9. PubMed ID: 25480521
[TBL] [Abstract][Full Text] [Related]
18. Etiologies and Clinical Outcomes of Patients With Secondary Hemophagocytic Lymphohistiocytosis at a Tertiary PICU.
Dao D; Xoay TD; Galeano BK; Phuc PH; Ouellette Y
Pediatr Crit Care Med; 2019 Jul; 20(7):e311-e318. PubMed ID: 31149968
[TBL] [Abstract][Full Text] [Related]
19. Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
Knaak C; Schuster FS; Spies C; Vorderwülbecke G; Nyvlt P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Shock; 2020 Jun; 53(6):701-709. PubMed ID: 31626037
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of adult critically ill patients with hemophagocytic lymphohistiocytosis in united states-analysis from an administrative database from 2007 to 2015.
Kumar G; Hererra M; Patel D; Nanchal R; Guddati AK
Am J Blood Res; 2020; 10(6):330-338. PubMed ID: 33489441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
